Ricardo Romiti Selected Research

Ricardo Romiti Research Topics

16	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2024 - 01/2009
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2023 - 06/2012
5	Crohn Disease (Crohn's Disease) 03/2017 - 06/2012
3	Psoriatic Arthritis 04/2023 - 09/2015
2	Infections 01/2024 - 05/2010
2	Cicatrix (Scar) 09/2021 - 10/2015
2	Pain (Aches) 01/2020 - 03/2014
2	Ulcerative Colitis 03/2017 - 09/2015
2	Alopecia (Baldness) 10/2015 - 12/2008
2	Molluscum Contagiosum 03/2014 - 03/2011
1	Latent Tuberculosis 01/2024
1	Tuberculosis (Tuberculoses) 01/2024
1	Polyneuropathies (Polyneuropathy) 09/2021
1	Cutaneous Lupus Erythematosus 09/2021
1	COVID-19 05/2021
1	Sialadenitis 05/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2021
1	Inflammation (Inflammations) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Pruritus (Itching) 01/2020
1	X-Linked Keratosis Follicularis Spinulosa Decalvans 11/2015
1	Diffuse alopecia 10/2015
1	Alopecia Areata 10/2015
1	Autoimmune Diseases (Autoimmune Disease) 09/2015
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 09/2015
1	Ankylosing Spondylitis 09/2015
1	Rheumatoid Arthritis 09/2015
1	Hypopigmentation (Hypomelanosis) 03/2014
1	Papillomavirus Infections 03/2014
1	Condylomata Acuminata (Genital Wart) 03/2014
1	Rheumatic Diseases (Rheumatism) 01/2009
1	Chancroid 01/2009

5	Infliximab (Remicade)FDA Link 11/2016 - 01/2009
3	Interleukin-17 (Interleukin 17)IBA 01/2024 - 03/2017
3	ixekizumabIBA 01/2024 - 03/2017
3	Biosimilar PharmaceuticalsIBA 01/2017 - 02/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2016 - 06/2012
2	Interleukin-23 (Interleukin 23)IBA 01/2024 - 04/2023
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 05/2021
2	Thalidomide (Thalomid)FDA Link 09/2021 - 05/2021
2	Antiviral Agents (Antivirals)IBA 05/2021 - 03/2014
2	CytokinesIBA 05/2021 - 05/2010
2	Etanercept (Enbrel)FDA Link 06/2017 - 11/2016
2	Monoclonal AntibodiesIBA 03/2017 - 09/2015
2	Proteins (Proteins, Gene)FDA Link 09/2015 - 05/2010
1	Tumor Necrosis Factor InhibitorsIBA 01/2024
1	Lenalidomide (CC 5013)FDA Link 09/2021
1	Interleukin-27 (Interleukin 27)IBA 05/2021
1	Acitretin FDA Link 05/2021
1	Interleukin-18 (Interleukin 18)IBA 05/2021
1	Interleukin-6 (Interleukin 6)IBA 05/2021
1	MucinsIBA 01/2020
1	NeuropeptidesIBA 01/2020
1	Adalimumab (Humira)FDA Link 11/2016
1	Ustekinumab (CNTO 1275)FDA Link 11/2016
1	Substance PIBA 11/2015
1	AlkaliesIBA 03/2014
1	SolutionsIBA 03/2014
1	potassium hydroxideIBA 03/2014
1	EnzymesIBA 05/2010
1	PhytohemagglutininsIBA 05/2010
1	Tuberculin (PPD)IBA 05/2010
1	InterleukinsIBA 05/2010
1	InterferonsIBA 05/2010
1	Interleukin-10 (Interleukin 10)IBA 05/2010
1	AntigensIBA 05/2010
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2009
1	ThiamphenicolIBA 01/2009
1	Periodic AcidIBA 12/2008
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2008
1	Hematoxylin (Haematoxylon)IBA 12/2008
1	amsonic acid (DAS)IBA 12/2008

9	Therapeutics 09/2021 - 01/2009
1	Chemoprevention 01/2024
1	Transcutaneous Electric Nerve Stimulation (TENS) 12/2018
1	Traction 10/2015
1	Electrodes (Electrode) 10/2015
1	Biological Therapy 01/2015
1	Cryotherapy (Therapy, Cold) 03/2014
1	Tattooing 03/2011
1	Phototherapy (Light Therapy) 01/2009